Three patents currently held, every record listed here
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Feb 2030. from the record
Of the 2 now held by other companies, 1 name IMEC VZW as their current owner, and 1 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Feb 2030
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2013 to 2036.
US 8,532,362
Scoring System to Monitor Natural or Drug-Modified Disease Progression in "Erosive Osteoarthritis" of the Interphalangeal Finger Joints
Aug 30, 2030
US 9,429,781
Filter for Selective Transmission of Visible Rays and Infrared Rays Using an Electrical Signal
Jun 24, 2032
US 10,548,516
Method and Device for Continuous In-Ear Hearing Health Monitoring on a Human Being
Jul 10, 2036
20182023202820332036
1 pending application: term is not computable until grant.Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2032 · High confidence
Also notable
Ends Aug 2030 · High confidence
Also notable
Ends Feb 2030 · High confidence
Filter for Selective Transmission of Visible Rays and Infrared Rays Using an Electrical Signal
US 9,429,781
The most cited patent in this portfolio, cited by 19 later US patents, top 25% of utility patents granted in 2016 in our data. Protection runs to 2032.
Scoring System to Monitor Natural or Drug-Modified Disease Progression in "Erosive Osteoarthritis" of the Interphalangeal Finger Joints
US 8,532,362
Renewed at every maintenance window since the 2013 grant; no more fees are due before its term ends in 2030.
Inhibitors of F18+ E Coli Binding
US 8,703,722
Renewed at every maintenance window since the 2014 grant; no more fees are due before its term ends in 2030.
Formerly held, still cited
Notable
Ends Oct 2035 · High confidence
The most cited patent in this portfolio, cited by 23 later US patents, top 25% of utility patents granted in 2017 in our data. Protection runs to 2035.
now held by IMEC VZW
Also notable
Ends Jul 2036 · High confidence
The newest of the three, granted 2020. It anchors the portfolio to 2036, later than anything else here.
now held by Eers Global Technologies Inc.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Showing 1 to 3 of 3
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,703,722 | Inhibitors of F18+ E Coli Binding held by Universiteit Gent In force · High confidence | In force | High confidence | |
| US 8,532,362 | Scoring System to Monitor Natural or Drug-Modified Disease Progression in "Erosive Osteoarthritis" of the Interphalangeal Finger Joints In force · High confidence | In force | High confidence | |
| US 9,429,781 | Filter for Selective Transmission of Visible Rays and Infrared Rays Using an Electrical Signal held by Samsung Electronics Co., Ltd. and Ghent University In force · High confidence | In force | High confidence |
Also on record, not counted in the 3: 2 patents in force now held by others · 3 patents ended · 1 application pending · 11 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.